Relationship between Didanosine Exposure and Surrogate Marker Response in Human Immunodeficiency Virus-Infected Outpatients

We used information available from routine clinic visits to characterize the pharmacokinetics of didanosine in 82 human immunodeficiency virus-infected patients. A total of 271 blood samples were collected for the measurement of didanosine concentrations in plasma (mean ± standard deviation [SD], 3....

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Adams, John M., Shelton, Mark J., Hewitt, Ross G., Grasela, Thaddeus H., DeRemer, Mary, Morse, Gene D.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105549/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9559790/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.4.821
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!